APVRS 25 Article Thumb Day 3 2
December 14, 2025

Innovation with Intention: Upcoming Retinal Disease Therapies on Spotlight at APVRS 2025 

From gene therapy to biosimilars and sustained delivery, experts weigh in what truly moves the needle for patients. On the…

Illustration of two hands holding two puzzle pieces with the first hands holding a blue one and on the top of the hand is the logo of Eli Lilly, the other hand is holding a yellow puzzle and under it is the MeiraGTx logo with a pink background
November 11, 2025

Eli Lilly Expands Gene Therapy Portfolio to Eye Care with $475M MeiraGTx Deal

Eli Lilly bets big on the future of gene therapy for vision restoration.  Eli Lilly is making another bold move…

latest posts
APVRS 25 Article Thumb Day 3 2
December 14, 2025

Innovation with Intention: Upcoming Retinal Disease Therapies on Spotlight at APVRS 2025 

Illustration of two hands holding two puzzle pieces with the first hands holding a blue one and on the top of the hand is the logo of Eli Lilly, the other hand is holding a yellow puzzle and under it is the MeiraGTx logo with a pink background
November 11, 2025

Eli Lilly Expands Gene Therapy Portfolio to Eye Care with $475M MeiraGTx Deal

AAO25 Article no2
October 18, 2025

Retina Roundup at AAO 2025: Fresh data, Familiar Challenges and the Future of Eye Care

Euretina_Session_10
September 7, 2025

From Rare to Repair: Inherited Retinal Disease Therapies Advance at Speed

Euretina Session 2
September 5, 2025

EURETINA 2025: What’s Next in the Neovascular AMD Playbook

ENCELTO implant releasing neurotrophic factor
August 15, 2025

U.S. Patient Receives World’s First ENCELTO Gene Therapy for MacTel

Artboard_1
July 16, 2025

AI System Eye2Gene Shows Promise in Rapid Genetic Diagnosis of Inherited Retinal Diseases

Nanoscope updates thumbnail
July 15, 2025

Nanoscope Kickstarts BLA Submission for Restorative RP Therapy, Adds to Advisory Board

Discover our fascinating content at issuu

explore